N-ethylmaleimide-stimulated arachidonic acid release in human platelets

Biochemical Pharmacology

Volumn 57, Issue 7, 1999, Pages 785-791

  Leoncini, Giuliana ^a   Signorello, Maria Grazia ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Arachidonic acid; Calcium; Cytosolic phospholipase A2; Human platelets; N ethylmaleimide; Reactive oxygen species

Indexed keywords

5,8,11,14 ICOSATETRAYNOIC ACID; ALKYLATING AGENT; ARACHIDONIC ACID; CALCIUM ION; DIPHENYLIODONIUM SALT; EGTAZIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FURA 2; GENISTEIN; N ETHYLMALEIMIDE; PHOSPHOLIPASE A2 INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0033009010     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00358-X     Document Type: Article

References (40)

1. 2. J Biol Chem. 264:1989;5768-5775.
2. 2 which preferentially hydrolyzes arachidonoyl residue. FEBS Lett. 282:1991;326-330.
3. 2 in human platelets. J Biol Chem. 268:1993;26796-26804.
4. Smith J.B., Willis A.L. Selective inhibition of synthesis of prostaglandin in human platelets. Nature New Biol. 230:1971;235-237.
5. Samuelsson B., Dahlén S.E., Lindgren J.A., Rouzer C.A., Serhan C.N. Leukotrienes and lipoxins Structures, biosynthesis, and biological effects . Science. 237:1987;1171-1176.
6. Egan R.W., Gale P.H., Baptista E.M., Kennicott K.L., VandenHeuvel W.J.A., Walker R.W., Fagerness P.E., Kuehl F.A. Jr. Oxidation reactions by prostaglandin cyclooxygenase-hydroperoxidase. J Biol Chem. 256:1981;7352-7361.
7. Kulmacz R.J., Tsai A.L., Palmer G. Heme spin states and peroxide-induced radical species in prostaglandin H synthase. J Biol Chem. 262:1987;10524-10531.
8. 2-dependent platelet activation. Platelets. 2:1992;87-90.
9. Iuliano L., Pedersen J.Z., Praticò D., Rotilio G., Violi F. Role of hydroxyl radicals in the activation of human platelets. Eur J Biochem. 221:1994;695-704.
10. 2 activation. Arch Biochem Biophys. 289:1991;47-52.
11. 2. FEBS Lett. 309:1992;190-192.
12. 2 by t-butylhydroperoxide. Biochem J. 292:1993;585-589.
13. Hornberger W., Patscheke H. Primary stimuli of icosanoid release inhibit arachidonoyl-CoA synthetase and lysophospholipid acyltransferase. Eur J Biochem. 187:1990;175-181.
14. Nelson J.M., Duane P.G., Rice K.L., Niewoehner D.E. Cadmium ion-induced alterations of phospholipid metabolism in endothelial cells. Am J Respir Cell Mol Biol. 5:1991;328-336.
15. 2 in endothelial cells. Biochem Pharmacol. 49:1995;57-63.
16. Brandt R., Keston A.S. Synthesis of diacetyldichlorofluorescin a stable reagent for fluorimetric analysis . Anal Biochem. 11:1965;6-9.
17. Leoncini G., Maresca M., Buzzi E., Piana A., Armani U. Platelets of patients affected with essential thrombocythemia are abnormal in plasma membrane and adenine nucleotide content. Eur J Haematol. 44:1990;115-119.
18. Rotondo S., Evangelista V., Manarini S., De Gaetano G., Cerletti C. Different requirement of intracellular calcium and protein kinase C for arachidonic acid release and serotonin secretion in cathepsin G-activated platelets. Thromb Haemost. 78:1997;919-925.
19. Leoncini G., Maresca M., Colao C. Oxidative metabolism of human platelets. Biochem Int. 25:1991;647-655.
20. Bell R.L., Kennerly D.A., Stanford N., Majerus P.W. Diglyceride lipase A pathway for arachidonate release from human platelets . Proc Natl Acad Sci USA. 76:1979;3238-3241.
21. 2 inhibit release of free arachidonate in thrombin-stimulated human platelets. J Biol Chem. 269:1994;15625-15630.
22. Bross T.E., Prescott S.M., Majerus P.W. RHC 80267 does not inhibit the diglyceride lipase pathway in intact platelets. Biochem Biophys Res Comm. 116:1983;68-74.
23. 2 is phosphorylated in collagen and thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase. J Biol Chem. 270:1995;25885-25892.
24. 2 activation in intact human platelets. FEBS Lett. 381:1996;244-248.
25. Kühn H., Holzhütter H.G., Schewe T., Hiebsch C., Rapoport S.M. The mechanism of inactivation of lipoxygenases by acetylenic fatty acids. Eur J Biochem. 139:1984;577-583.
26. O'Donnell V.B., Tew D.G., Jones O.T.G., England P.J. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J. 290:1993;41-49.
27. Stuehr D.J., Fasehum O.A., Kwon N.S., Gross S.S., Gonzales J.A., Levi R., Nathan C.F. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J. 5:1991;98-103.
28. 2+-independent catalytic domain. J Biol Chem. 269:1994;18239-18249.
29. 2. J Biol Chem. 269:1994;19480-19487.
30. 2 activation by phosphorylation in mouse peritoneal macrophages. J Biol Chem. 268:1993;24506-24513.
31. 2. J Clin Invest93: 1583-1519, 1994.
32. 2 by phosphorylation in rat mesangial cells. J Clin Invest. 93:1994;1224-1233.
33. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem. 268:1993;1960-1964.
34. 2 is phosphorylated and activated by MAP kinase. Cell. 72:1993;269-278.
35. 2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci USA. 89:1992;6147-6151.
36. Golden A., Brugge J.S., Shattil S.J. Role of platelet membrane glycoprotein IIb-IIIa in agonist-induced tyrosine phosphorylation of specific platelet proteins. J Cell Biol. 111:1990;3117-3127.
37. Vostal J.G., Jackson W.L., Shulman N.R. Cytosolic and stored calcium antagonistically control tyrosine phosphorylation of specific platelet proteins. J Biol Chem. 266:1991;16911-16916.
38. 2+ mobilisation in human platelets by affecting polyphosphoinositide turnover. Biochem Pharmacol. 46:1993;395-403.
39. Fialkow L., Chan C.K., Grinstein S., Downey G.P. Regulation of tyrosine phosphorylation in neutrophils by the NADPH oxidase. Role of reactive oxygen intermediates. J Biol Chem. 268:1993;17131-17137.
40. 2 in intact human neutrophils but not in the cell-free system. Biochem Biophys Res Comm. 138:1986;1099-1105.